Search

everythinglearnresearchcommunity

for

Search:↓

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Id2 gene helps keep hair follicle stem cells inactive.

IL-15 promotes hair growth and protects hair follicles.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

CD27 and IL-35 can help diagnose alopecia areata linked to bacterial infections.

TCDD changes skin cell growth and keratin production in mice.

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Understanding Wnt-β-catenin signaling is key to hair growth and could impact conditions like baldness.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Stem cells control their future role by changing ERK signal timing, affecting tissue regeneration and cancer.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Lower SMAD2/3 activation predicts more severe skin cancer.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

TEDAR is crucial for skin cell differentiation and barrier formation.